February 29, 2024 · Form 4 insider transaction
JOHNSON & JOHNSON bought 189 shares of CVRX at $0.24 per share, a transaction worth $44.79. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 6 days after the transaction.
The securities reported as being indirectly beneficially owned by Johnson & Johnson, the designated Reporting Person, are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc. ("JJDC"), a wholly-owned subsidiary of Johnson & Johnson.